Author Contributions
Conceived and designed the experiments: ALR, LMP. Analyzed the data: ALR, LMP, ST, HR, POD. Wrote the first draft of the manuscript: ALR, LMP. Contributed to the writing of the manuscript: ST, HR, POD. Agreed with manuscript results and conclusions: ALR, LMP, ST, HR, POD. Jointly developed the structure and arguments for the paper: ALR, LMP, ST, HR, POD. Made critical revisions and approved final version: ALR, LMP. All the authors reviewed and approved the final manuscript.
Go to:
REFERENCES
1. Lee PA, Houk CP, Ahmed SF, Hughes IA, Houk A, Hughes IA. Consensus statement on management of intersex disorders. Pediatrics. 2006;118(2):e488–500. [
PubMed] [
Google Scholar]
2. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2013;21(3):245–91. [
PubMed] [
Google Scholar]
3. Intersex Society of North America (ISNA) What is Intersex? 2008. [Accessed June 1, 2016]. Available at:
http://www.isna.org/faq/what_is_intersex.
4. Crain DA, Janssen SJ, Edwards TM, et al. Female reproductive disorders: the roles of endocrine-disrupting compounds and development timing. Fertil Steril. 2008;90(4):911–40. [
PMC free article] [
PubMed] [
Google Scholar]
5. Fowler PA, Bellingham M, Sinclair KD, et al. Impact of endocrine-disrupting compounds (EDCs) on female reproductive health. Mol Cell Endocrinol. 2012;355:231–9. [
PubMed] [
Google Scholar]
6. Earl-Gray L, Wilson VS, Stoker T, et al. Adverse effects of environmental antiandrogens and androgens on reproductive development in mammals. Int J Androl. 2006;29(1):96–104. [
PubMed] [
Google Scholar]
7. Zoeller RT, Brown TR, Doan LL, et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology. 2012;153(9):4097–110. [
PMC free article] [
PubMed] [
Google Scholar]
8. Hamlin HJ, Guillette LJ., Jr Birth defects in wildlife: the role of environmental contaminants as inducers of reproductive and developmental dysfunctions. Syst Biol Reprod Med. 2010;56(2):113–21. [
PubMed] [
Google Scholar]
9. Niemuth NJ, Klapper RD. Emerging wastewater contaminant metformin causes intersex and reduced fecundity in fish. Chemosphere. 2015;135:38–45. [
PubMed] [
Google Scholar]
10. Accord Alliance (n.d.). Intersex. [Accessed June 1, 2016]. Available at
http://www.accordalliance.org/glossary/intersex/
11. Lilford RJ, Dear PR. The intersex baby. Br J Hosp Med (Lond) 1987;37(1):28–30. [
PubMed] [
Google Scholar]
12. World Health Organization (WHO) Gender and Genetics: Genetic Components of Sex and Gender. [Accessed July 27, 2015]. Available at:
http://www.who.int/genomics/gender/en/index1.html.
13. Ahmed SF, Dobbie R, Finlayson AR, et al. Prevalence of hypospadias and other genital anomalies among singleton births, 1988–1997, in Scotland. Arch Dis baby ******* Neonatal Ed. 2004;89:F149–51. [
PMC free article] [
PubMed] [Google Scholar]
14. Gaspari L, Paris F, Jandel C, et al. Prenatal environmental risk factors for genital malformations in a population of 1442 French male newborns: a nested case–control study. Hum Reprod. 2011;26(11):3155–62. [
PubMed] [
Google Scholar]
15. Svechnikov K, Stukenborg JB, Savchuck I, Söder O. Similar causes of various reproductive disorders in early life. Asian J Androl. 2014;16:50–9. [
PMC free article] [
PubMed] [
Google Scholar]
16. Sharpe R. Hormones and testis development and the possible adverse effects of environmental chemicals. Toxicol Lett. 2001;120:221–32. [
PubMed] [
Google Scholar]
17. Kavlock RJ, Daston GP, DeRosa C, et al. Research needs for the assessment of health and environmental effects of endocrine disruptor: a report of the US EPA-sponsored workshop. Environ Health Perspect. 1996;104(Suppl 4):715–40. [
PMC free article] [
PubMed] [
Google Scholar]
18. Newbold RR. Developmental exposure to endocrine-disrupting chemicals programs for reproductive tract alterations and obesity in later years. Am J Clin Nutr. 2011;94(6 Supple):1939S–42S. [
PMC free article] [
PubMed] [
Google Scholar]
19. Acerini CL, Hughes IA. Endocrine disrupting chemicals: a new and emerging public health problem? Arch Dis baby. 2006;91:633–8. [
PMC free article] [
PubMed] [Google Scholar]
20. Laino L, Majore S, Preziosi N, et al. Disorders of sex development: a genetic study of patients in a multidisciplinary clinic. Endocr Connect. 2014;3(4):180–92. [
PMC free article] [
PubMed] [
Google Scholar]
21. World Health Organization (WHO) Gender and Genetics: Genetic Components of Sex and Gender. [Accessed July 27, 2015]. Available at:
http://www.who.int/genomics/gender/en/index1.html.
22. National Institute of Health (NIH) NIH FY 2016–2020 Strategic plan to advance research on the health and well-bring of sexual and gender minorities. [Accessed October 11, 2015]. Available at:
http://edi.nih.gov/sites/default/files/EDI_Public_files/sgm-strategic-plan.pdf.
23. Hughes IA. Disorders of sex development: a new definition and classification. Best Pract Res Clin Endocrinol Metab. 2008;22(1):119–34. [
PubMed] [
Google Scholar]
24. Öcal B, Berberoğlu M, Siklar Z, et al. Clinical review of 95 patients with 46, XX disorders of sex development based on the New Chicago classification. J Pediatr Adolesc Gyneco. 2015;28(1):6–11. [
PubMed] [
Google Scholar]
25. Speiser PW, Azziz R, Baskin LS, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95(9):4133–60. [
PMC free article] [
PubMed] [
Google Scholar]
26. Frisén L, Nordenström A, Falhammar H, et al. Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21 A2 deficiency. J Clin Endocrinol Metab. 2009;94(9):3432–9. [
PubMed] [
Google Scholar]
27. Erdoğan S, Kara C, Uçaktürk A, Aydin M. Etiological classification and clinical assessment of children and adolescents with disorders of sex development. J Clin Res Pediatr Endocrinol. 2011;3(2):77–83. [
PMC free article] [
PubMed] [
Google Scholar]
28. Kousta E, Papathanasiou A, Skordis N. Sex determination and disorders of sex development according to the revised nomenclature and classification in 46, XX individuals. Hormones. 2010;9(3):218–31. [
PubMed] [
Google Scholar]
29. Frisén L, Nordenström A, Falhammar H, et al. Gender role behaviour, sexuality, and psychosocial adaptation in women and congenital adrenal hyperplasia due to CYP21 A2 deficiency. J Clin Endocrinol Metab. 2009;94(9):3432–9. [
PubMed] [
Google Scholar]
30. Liang HY, Chang HL, Chen CY, Chang PY, Lo FS, Lee LW. Psychiatric manifestation in young females with congenital adrenal hyperplasia in Taiwan. Chang Gung Med J. 2008;31:66–73. [
PubMed] [
Google Scholar]
31. Blackless M, Charuvastra A, Derryck A, Fausto-Sterling A, Lauzanne K, Lee E. How sexually dimorphic are we? Review and synthesis. Am J Hum Biol. 2000;12:151–66. [
PubMed] [
Google Scholar]
32. NTP (National Toxicology Program) Endocrine Disruptors Low-Dose Peer Review. Research Triangle Park: NTP; 2003. [Accessed March, 22, 2016]. Final report of the endocrine disruptors low-dose peer review panel. Available at:
http://ntp.niehs.nih.gov/ntp/htdocs/liason/lowdosepeerfinalrpt.pdf. [
Google Scholar]
33. Vom Saal FS, Timms BG, Montano MM, et al. Prostate enlargement in mice due to ******* exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci U S A. 1997;94:2056–62. [
PMC free article] [
PubMed] [Google Scholar]
34. Palanza P, Howdeshell KL, Parmigiani S, vom Saal FS. Exposure to a low dose of Bisphenol A during ******* life or in adulthood alters material behavior in mice. Env Health Perspect. 2002;110(Suppl 3):415–22. [
PMC free article] [
PubMed] [Google Scholar]
35. Zoeller RT, Brown TR, Doan LL, et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology. 2012;153(9):4097–110. [
PMC free article] [
PubMed] [
Google Scholar]
36. Ostby J, Monosson E, Kelce WR, Gray LE., Jr Environmental antiandrogens: low doses of the fungicide vinclozolin alter sexual differentiation of the male rate. Toxicol Ind Health. 1999;15:48–64. [
PubMed] [
Google Scholar]
37. Prener A, Engholm G, Jensen OM. Genital anomalies and risk for testicular cancer in Danish men. Epidemiology. 1996;7(1):14–9. [
PubMed] [
Google Scholar]
38. Wang MH, Baskin LS. Endocrine disruptors, genital development, and hypospadias. J Androl. 2008;29(5):499–505. [
PubMed] [
Google Scholar]
39. Newbold RR. Developmental exposure to endocrine-disrupting chemicals programs for reproductive tract alterations and obesity in later years. Am J Clin Nutr. 2011;94(6 supple):1939S–42S. [
PMC free article] [
PubMed] [
Google Scholar]
40. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects: opinion. Hum Reprod. 2001;16(5):972–8. [
PubMed] [
Google Scholar]
41. Bartman T, Hove J. Mechanics and function in heart morphogenesis. Dev Dyn. 2005;233:373–81. [
PubMed] [
Google Scholar]
42. Anderson RH, Webb S, Brown NA, Lamers W, Moorman A. Development of the heart: (3) formations of the ventricular outflow tracts, arterial valves and intrapericardial arterial trunks. Heart. 2003;9(9):1110–8. [
PMC free article] [
PubMed] [
Google Scholar]
43. Costa VM, Carvalho F, Duarte JA, de Lourdes Bastos M, Remião F. The heart as a target for xenobiotic toxicity: the cardiac susceptibility to oxidative stress. Chem Res Toxicol. 2013;26:1285–311. [
PubMed] [
Google Scholar]
44. Korones S. Anatomic aspects of ******* development. Glob Libr Womens Med. 2008:1–22. doi: 10.3843/GLOWM.10102. [
CrossRef] [Google Scholar]
45. Rauhut-Klaban M, Bruska M, Woźniak W. Early trabeculation and close of the interventricular foramen in staged human embryos. Folia Morphol. 2008;67(1):13–8. [
PubMed] [
Google Scholar]
46. Anderson RH, Webb S, Brown NA, Lamers W, Moorman A. Development of the heart: (3) formations of the ventricular outflow tracts, arterial valves and intrapericardial arterial trunks. Heart. 2003;9(9):1110–8. [
PMC free article] [
PubMed] [
Google Scholar]
47. Artamonova GV, Shapovlova EB, Maksimov SA, Skripchenko AE, Ogarkov Mlu. The environment as a risk factor for coronary heart disease in urbanized regions with developed chemical industry. Kardiologiia. 2012;52(10):86–90. [
PubMed] [
Google Scholar]
48. Thornton PS, Satin-Smith MS, Glaser HK, et al. Familial hyperinsulism with apparent autosomal dominant inheritance: clinical and genetic differences from the autosomal recessive variant. J Pediatr. 1998;132(1):9–14. [
PubMed] [
Google Scholar]
49. Costa VM, Carvalho F, Duarte JA, de Lourdes Bastos M, Remião F. The heart as a target for xenobiotic toxicity: the cardiac susceptibility to oxidative stress. Chem Res Toxicol. 2013;26:1285–311. [
PubMed] [
Google Scholar]
50. Gorini F, Chiappi E, Gargani L, Picano E. Potential effects of environmental chemical contamination in congenital heart disease. Pediatr Cardiol. 2014;35:559–68. [
PubMed] [
Google Scholar]
51. Gorlin RJ, Kantaputra P, Aughton DJ, Julliken JB. Marked female predilection in some syndromes associate with facial hemangiomas. Am J Med Genet. 1994;52:130–5. [
PubMed] [
Google Scholar]
52. Ermito S, Dinatale A, Carrara S, Cavaliere A, Imbruglia L, Recupero S. Prenatal diagnosis of limb abnormalities: role of ******* ultrasonography. J Prenat Med. 2009;3(2):18–22. [
PMC free article] [
PubMed] [Google Scholar]
53. Lingaiah K, Parshwanath BA, Mysore SR, Krishnamurthy B, Ramachandra NB. A rare case of congential heart disease with ambiguous genitalia. Indian J Hum Genet. 2010;16(3):166–8. [
PMC free article] [
PubMed] [
Google Scholar]
54. Low Y, Deshpande AV, Hutson JM. Lethal comorbidity with genital anomaly in the *******. J Pediatr Urol. 2006;2(6):534–8. [
PubMed] [Google Scholar]
55. Bondy CA, Ceniceros I, Van PL, Bakalov VK, Rosing DR. Prolonged rate-corrected QT interval and other electrocardiogram abnormalities in girls with Turner Syndrome. Pediatrics. 2006;118(4):e1220–5. [
PubMed] [
Google Scholar]
56. Lippe B. Turner syndrome. Endocrinol Metab Clin North Am. 1991;20:121–52. [
PubMed] [
Google Scholar]
57. Davenport ML. Approach to the patient with Turner Syndrome. J Clin Endocrinol Metab. 2010;95:1487–95. [
PubMed] [
Google Scholar]
58. Stenberg AE, Nylen O, Windh M, Hultcrantz M. Otological problems in children with Turner’s syndrome. Hear Res. 1998;124(1–2):85–90. [
PubMed] [
Google Scholar]
59. Bondy CA, Ceniceros I, Van PL, Bakalov VK, Rosing DR. Prolonged rate-corrected QT interval and other electrocardiogram abnormalities in girls with Turner Syndrome. Pediatrics. 2006;118(4):e1220–5. [
PubMed] [
Google Scholar]
60. Bolar K, Hoffman AR, Maneatis T, Lippe B. Long-term safety of recombinant human growth hormone in turner syndrome. J Clin Endocrinol Metab. 2008;93(2):344–51. [
PubMed] [
Google Scholar]
61. Low Y, Deshpande AV, Hutson JM. Lethal comorbidity with genital anomaly in the *******. J Pediatr Urol. 2006;2(6):534–8. [
PubMed] [Google Scholar]
62. Liang HY, Chang HL, Chen CY, Chang PY, Lo FS, Lee LW. Psychiatric manifestation in young females with congenital adrenal hyperplasia in Taiwan. Chang Gung Med J. 2008;31:66–73. [
PubMed] [
Google Scholar]
63. Fausto-Sterling A. The dynamic development of gender variability. J Homosex. 2012;59:398–421. [
PubMed] [
Google Scholar]
64. Laino L, Majore S, Presiosi N, et al. Disorders of sex development: a genetic study of patients in a multidisciplinary clinic. Endocr Connect. 2014;3(4):180–192. [
PMC free article] [
PubMed] [
Google Scholar]
65. The American Psychiatric Association Gender Dysphoria. 2013. [Accessed April 13, 2016]. Available at:
http://www.dsm5.org/documents/genderdysphoriafactsheet.pdf.
66. Guillette LJ, Jr, Gross TS, Masson GR, Matter JM, Percival HF, Woodward AR. Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida. Environ Health Perspect. 1994;102:680–8. [
PMC free article] [
PubMed] [
Google Scholar]
67. Colborn T, Clement C, editors. Chemically Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection. Princeton, NJ: Princeton Scientific Pub. Co; 1992. [
Google Scholar]
68. Semenza JC, Tolbert PE, Rubin CH, Guillette LJ, Jr, Jackson RJ. Reproductive toxins and alligator abnormalities at Lake Apopka, Florida. Environ Health Perspect. 1997;105(10):1030–2. [
PMC free article] [
PubMed] [
Google Scholar]
69. Bortone SA, Davis WP. Fish intersexuality as indicator of environmental stress. Bioscience. 1994:165–72. [
Google Scholar]
70. Jobling S, Beresford N, Nolan M, et al. Altered sexual maturation and gamete production in wild roach (
Rutilus rutilus) living in rivers that receive treated sewage effluents. Biol Reprod. 2002;66(2):272–81. [
PubMed] [
Google Scholar]
71. Parks LG, Lambright CS, Orlando EF, Guilette LJ, Jr, Ankley GT, Gray LE., Jr Masculinization of female mosquitofish in Kraft Mill effluent-contaminated Fenholloway River water is associated with androgen receptor agonist activity. Toxicol Sci. 2001;62:257–67. [
PubMed] [
Google Scholar]
72. Aravindakshan J, Paquet V, Gregory M, et al. Consequences of xenoestrogen exposure on male reproductive function in spottail shiners (
Notropis hudsonius) Toxicol Sci. 2004;78:156–65. [
PubMed] [
Google Scholar]
73. Ortiz-Zarragoitia M, Bizarro C, Rojo-Bartolomé I, de Cerio OD, Cajaraville MP, Cancio I. Mugilid fish are sentinels of exposure to endocrine disrupting compounds in coastal and estuarine environments. Mar *******. 2014;12(9):4756–82. [
PMC free article] [
PubMed] [Google Scholar]
74. Niemuth NJ, Klapper RD. Emerging wastewater contaminant metformin causes intersex and reduced fecundity in fish. Chemosphere. 2015;135:38–45. [
PubMed] [
Google Scholar]
75. Jobling S, Burn RW, Thorpe K, Williams R, Tyler C. Statistical modeling suggest that antiandrogens in effluents from wastewater treatment works contribute to widespread sexual disruption in fish living in English rivers. Environ Health Perspect. 2009;117:797–802. [
PMC free article] [
PubMed] [
Google Scholar]